2026 is shaping up to be a defining year for health tech. The industry is moving decisively beyond pilots and proofs-of-concept into real-world deployment at scale. AI is no longer experimental—it is becoming foundational infrastructure. As the year unfolds, the question is no longer whether these technologies work, but how they will fundamentally reshape care delivery, clinical workflows, and the economics of healthcare itself.

Having built and scaled a radiology AI platform that now processes over 10,000 scans daily across 1,500+ healthcare facilities, we have observed several patterns that will shape the year ahead. Here are seven predictions for the health tech industry for 2026-27.

1. AI-Assisted Reporting Will Become Standard of Care in Radiology

The numbers tell a compelling story. The FDA has now authorised over 1,350 AI-enabled medical devices, with radiology accounting for more than 870 of them. According to recent surveys, 85% of radiologists believe AI will help ensure greater consistency in patient examinations, while 66% of physicians in the United States already report using AI tools in daily practice.

In 2026-27, we will see the conversation shift from “does AI work?” to “how do we deploy it responsibly at scale?” The real value will come not from standalone point solutions but from deeply integrated clinical pathways where AI augments radiologist productivity. Early adopters have demonstrated 6x productivity gains through structured AI-clinical workflows. Expect these models to become the new baseline, particularly in high-volume settings where the radiologist shortage is most acute.

Vision Language Models for draft report generation will emerge as the next frontier. These systems can analyse imaging studies and generate preliminary reports that radiologists then review and refine, fundamentally changing how reporting workflows operate.

2. Medical Data Annotation Will Become a Strategic Competitive Moat

The healthcare data annotation market, valued at approximately $205 million in 2024, is projected to reach $1.3 billion by 2033, growing at nearly 23% annually. This is not a peripheral trend. It reflects a fundamental truth about healthcare AI: the quality of your training data determines the quality of your models.

In 2026-27, organisations that have invested in building proprietary, clinically validated datasets will find themselves with an insurmountable advantage. Unlike general-purpose AI, where models can be commoditised, healthcare AI requires domain-specific annotation by trained medical professionals who understand clinical context, coding standards like ICD-10 and SNOMED, and the nuances of real-world patient data.

The winners will be those who have accumulated billions of annotated images and clinical data points over years of operations. This is not something that can be replicated quickly or purchased off the shelf. Expect data assets to become the most valuable component of healthcare AI valuations.

3. Hospitals Will Shift from Capex to Outcome-Based Technology Investments

Hospital technology spending is under increasing pressure. Recent surveys indicate that 75% of hospital executives report macro factors impacting their capital equipment decisions, with 40% planning to cut or defer capital spending. At the same time, healthcare system operating expenses have outpaced revenue gains by nearly five percentage points, with expenses growing 17% while revenue increased only 12.5%.

This creates a significant opportunity for technology models that shift the burden from large upfront capital expenditure to operational expense tied to outcomes. Hospitals will increasingly favour partners who can deliver measurable ROI through workflow efficiency rather than requiring heavy infrastructure investments. The “technology as a service” model, where payment is linked to scans processed, reports delivered, or outcomes achieved, will gain significant traction.

In India specifically, approximately 50% of hospitals now allocate 20-50% of their IT budgets to digital innovation, with overall healthcare IT spending projected to grow 20-25% over the next two to three years. The smart money will flow toward solutions that demonstrate clinical credibility and sustainable unit economics.

4. Agentic AI Will Move from Concept to Clinical Reality

The healthcare industry spent 2025 exploring generative AI. In 2026-27, we will see the emergence of agentic AI: systems that do not merely respond to prompts but can autonomously plan, execute, and complete multi-step clinical and administrative workflows.

These digital co-workers will begin handling tasks like patient scheduling, prior authorisation, documentation, and care coordination without requiring human intervention for each step. One health system has already reported that AI-powered note summarisation reduced clinicians’ chart review time by over 98% while achieving 99% accuracy, higher than human processes.

The shift is conceptual as much as technological. Organisations will begin thinking of AI not as software to be purchased but as “hireable” capacity to be deployed. With projections of an 11 million health worker shortage globally by 2030, agentic AI is transitioning from a luxury to an operational necessity.

5. AI Governance Will Become a Board-Level Priority

The rapid adoption of AI has outpaced governance frameworks. Studies show that only 18% of healthcare organisations consider themselves “AI-ready” from a governance perspective. Meanwhile, shadow AI, where staff independently adopt AI tools without organisational oversight, surged across healthcare organisations in 2025.

In 2026-27, we will see healthcare leaders forced to implement formalised AI governance models. Organisations will explore “AI safe zones,” controlled environments where staff can experiment with approved AI tools and datasets. The EU AI Act will require radiology AI to meet “high-risk” compliance standards, documenting training data curation, bias checks, and human oversight policies.

Trust will become the defining success factor. Healthcare providers want transparency about the source of AI recommendations: who is writing it, how it arrives at answers, and what assumptions are being made. The organisations that can demonstrate responsible, auditable AI will be the ones that scale.

6. Hybrid Care Models Will Accelerate Beyond Telehealth

The pandemic catalysed telemedicine adoption, but 2026 will see the maturation of hybrid care models that combine virtual and in-person services in more sophisticated ways. Remote patient monitoring programs that integrate wearables, structured questionnaires, and predictive algorithms are already demonstrating 20-50% reductions in 30-day readmissions for conditions like heart failure.

In India, the digital health market is projected to grow from $8.8 billion in 2024 to $47.8 billion by 2033. The real opportunity lies in moving diagnostic and specialist services out of tertiary hospitals and into community settings, enabled by AI-powered tools that can bring specialist-level insights to primary care facilities.

This is particularly relevant for radiology, where cloud-based AI platforms can enable high-quality interpretation regardless of where the imaging equipment is located. The hub-and-spoke model, with expert radiologists supported by AI reviewing scans from distributed facilities, will become increasingly common.

7. India Will Emerge as a Global Health Tech Innovation Hub

India’s health tech sector received $828 million in funding in the first half of 2025 alone, signalling continued investor confidence. With over 11,000 health tech startups and government initiatives like the Ayushman Bharat Digital Mission driving digital health adoption, India is uniquely positioned to develop solutions that can scale globally.

The combination of a large patient population, growing digital infrastructure, and a deep talent pool in engineering and clinical sciences creates conditions that are difficult to replicate elsewhere. In the upcoming years, we will see more Indian health tech companies expanding internationally, bringing cost-effective, AI-powered solutions developed and validated in India to markets in the United States, the Middle East, and Southeast Asia.

The key differentiator will be operational excellence at scale. Building healthcare AI is not just about developing algorithms; it is about integrating them into clinical workflows in ways that deliver measurable outcomes for patients and providers alike.

The Years Ahead

The health tech industry is moving from experimentation to industrialisation. The technologies that seemed like science fiction five years ago are now being deployed in hospitals across the world. The companies that will lead in 2026 will be those that combine deep domain expertise with operational discipline, delivering solutions that are not just technically impressive but genuinely transformative for patient care.

Views expressed by: Kalyan Sivasailam, CEO & Founder, 5C Network

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Disclaimer: The views and opinions expressed in this article are solely those of the author and do not necessarily reflect the official policy or views of any organisation. The content is intended for informational and educational purposes only and should not be construed as medical advice.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!